While these differences did not reach statistical significance, likely because of our small sample size, there was a noticeable numerical trend favoring patients aged under 60 years.
← all excerpts
Real-world effectiveness of azvudine for patients infected with the SARS-CoV-2 omicron subvariant BA.5 in an intensive care unit.
1
—
—